奥西默替尼
医学
肺癌
癌症研究
肿瘤科
内科学
表皮生长因子受体
癌症
埃罗替尼
作者
Yi−Long Wu,Masahiro Tsuboi,Jie He,Thomas John,Christian Grohé,Margarita Majem,Jonathan W. Goldman,К. К. Лактионов,Sang‐We Kim,Terufumi Kato,Huu-Vinh Vu,Shun Lü,Kye Young Lee,Charuwan Akewanlop,Chong‐Jen Yu,Filippo de Marinis,Laura Bonanno,Manuel Dómine,Frances A. Shepherd,Lingmin Zeng
标识
DOI：10.1056/nejmoa2027071
摘要
Osimertinib is standard-of-care therapy for previously untreated epidermal growth factor receptor (EGFR) mutation–positive advanced non–small-cell lung cancer (NSCLC). The efficacy and safety of osimertinib as adjuvant therapy are unknown.
科研通智能强力驱动
Strongly Powered by AbleSci AI
SYLH
科研助手6
昏睡的蟠桃
cdercder
pluto
落叶
平常的毛豆
轻松小张
科研小民工
椰子在长江送礼物
iNk
nozero
back you up
pcr163
jenningseastera
彭于彦祖
zho
机灵柚子
illusion2019
qiao
皖公网安备34019202002308
